CNS Pharmaceuticals, Inc. (CNSP) › Total AssetsCNS Pharmaceuticals, Inc. (CNSP) — Total AssetsAnnual figures by period end, from SEC filings.2018-12-31: $683.3K2019-12-31: $7.91M2020-12-31: $15.85M2021-12-31: $8.76M2022-12-31: $13.05M2023-12-31: $1.70M2024-12-31: $8.70M2025-12-31: $8.62M$8.62M2018-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$8.62M-0.9%2026-03-31Balance as of period end2024-12-31$8.70M+411.6%2026-03-31Balance as of period end2023-12-31$1.70M-87.0%2025-03-31Balance as of period end2022-12-31$13.05M+49.1%2024-04-01Balance as of period end2021-12-31$8.76M-44.8%2023-03-31Balance as of period end2020-12-31$15.85M+100.4%2022-03-03Balance as of period end2019-12-31$7.91M+1057.9%2021-02-12Balance as of period end2018-12-31$683.3K—2020-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)